Innoviva Free Cash Flow Yield vs Capex To Revenue Analysis

INVA Stock  USD 19.05  0.09  0.47%   
Innoviva financial indicator trend analysis is infinitely more than just investigating Innoviva recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innoviva is a good investment. Please check the relationship between Innoviva Free Cash Flow Yield and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

Free Cash Flow Yield vs Capex To Revenue

Free Cash Flow Yield vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innoviva Free Cash Flow Yield account and Capex To Revenue. At this time, the significance of the direction appears to have pay attention.
The correlation between Innoviva's Free Cash Flow Yield and Capex To Revenue is -0.88. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Innoviva, assuming nothing else is changed. The correlation between historical values of Innoviva's Free Cash Flow Yield and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Innoviva are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Free Cash Flow Yield i.e., Innoviva's Free Cash Flow Yield and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.88
Relationship DirectionNegative 
Relationship StrengthSignificant

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most indicators from Innoviva's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 5.50, whereas Discontinued Operations is forecasted to decline to (89.7 M).

Innoviva fundamental ratios Correlations

0.840.710.390.09-0.190.180.130.160.030.34-0.36-0.05-0.120.290.680.97-0.180.090.270.68-0.050.860.020.26-0.36
0.840.860.46-0.3-0.37-0.37-0.410.260.230.340.080.12-0.620.420.580.78-0.57-0.440.330.51-0.380.81-0.450.220.08
0.710.860.46-0.58-0.77-0.36-0.37-0.050.080.440.20.0-0.540.260.470.72-0.44-0.42-0.060.49-0.710.64-0.220.080.2
0.390.460.460.04-0.33-0.21-0.07-0.41-0.49-0.09-0.3-0.3-0.27-0.480.490.43-0.24-0.09-0.210.74-0.220.33-0.150.66-0.3
0.09-0.3-0.580.040.770.70.7-0.07-0.39-0.25-0.86-0.250.65-0.290.130.080.510.730.110.330.92-0.060.360.4-0.86
-0.19-0.37-0.77-0.330.770.330.280.320.04-0.32-0.40.110.350.08-0.19-0.260.20.340.43-0.180.92-0.14-0.040.11-0.4
0.18-0.37-0.36-0.210.70.330.97-0.11-0.28-0.03-0.72-0.280.92-0.240.140.230.760.97-0.10.180.6-0.030.870.05-0.72
0.13-0.41-0.37-0.070.70.280.97-0.23-0.42-0.2-0.75-0.420.93-0.450.210.180.810.99-0.170.230.56-0.120.910.14-0.75
0.160.26-0.05-0.41-0.070.32-0.11-0.230.910.190.40.47-0.250.680.06-0.01-0.39-0.250.78-0.410.090.32-0.32-0.320.4
0.030.230.08-0.49-0.390.04-0.28-0.420.910.30.680.55-0.380.79-0.1-0.11-0.47-0.440.6-0.56-0.20.24-0.35-0.470.68
0.340.340.44-0.09-0.25-0.32-0.03-0.20.190.30.150.49-0.230.450.090.34-0.42-0.230.060.09-0.330.55-0.15-0.340.15
-0.360.080.2-0.3-0.86-0.4-0.72-0.750.40.680.150.44-0.640.45-0.31-0.41-0.57-0.780.15-0.67-0.67-0.12-0.49-0.471.0
-0.050.120.0-0.3-0.250.11-0.28-0.420.470.550.490.44-0.40.5-0.07-0.13-0.46-0.410.45-0.47-0.060.18-0.41-0.090.44
-0.12-0.62-0.54-0.270.650.350.920.93-0.25-0.38-0.23-0.64-0.4-0.4-0.16-0.030.850.95-0.330.040.59-0.30.88-0.03-0.64
0.290.420.26-0.48-0.290.08-0.24-0.450.680.790.450.450.5-0.4-0.130.21-0.5-0.450.44-0.29-0.070.46-0.43-0.410.45
0.680.580.470.490.13-0.190.140.210.06-0.10.09-0.31-0.07-0.16-0.130.59-0.090.150.420.51-0.070.490.090.43-0.31
0.970.780.720.430.08-0.260.230.18-0.01-0.110.34-0.41-0.13-0.030.210.59-0.10.150.050.73-0.070.830.110.26-0.41
-0.18-0.57-0.44-0.240.510.20.760.81-0.39-0.47-0.42-0.57-0.460.85-0.5-0.09-0.10.82-0.330.050.46-0.540.820.17-0.57
0.09-0.44-0.42-0.090.730.340.970.99-0.25-0.44-0.23-0.78-0.410.95-0.450.150.150.82-0.180.220.61-0.140.890.14-0.78
0.270.33-0.06-0.210.110.43-0.1-0.170.780.60.060.150.45-0.330.440.420.05-0.33-0.18-0.220.240.33-0.34-0.030.15
0.680.510.490.740.33-0.180.180.23-0.41-0.560.09-0.67-0.470.04-0.290.510.730.050.22-0.220.040.480.080.53-0.67
-0.05-0.38-0.71-0.220.920.920.60.560.09-0.2-0.33-0.67-0.060.59-0.07-0.07-0.070.460.610.240.04-0.130.250.26-0.67
0.860.810.640.33-0.06-0.14-0.03-0.120.320.240.55-0.120.18-0.30.460.490.83-0.54-0.140.330.48-0.13-0.22-0.04-0.12
0.02-0.45-0.22-0.150.36-0.040.870.91-0.32-0.35-0.15-0.49-0.410.88-0.430.090.110.820.89-0.340.080.25-0.22-0.02-0.49
0.260.220.080.660.40.110.050.14-0.32-0.47-0.34-0.47-0.09-0.03-0.410.430.260.170.14-0.030.530.26-0.04-0.02-0.47
-0.360.080.2-0.3-0.86-0.4-0.72-0.750.40.680.151.00.44-0.640.45-0.31-0.41-0.57-0.780.15-0.67-0.67-0.12-0.49-0.47
Click cells to compare fundamentals

Innoviva Account Relationship Matchups

Innoviva fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets724.8M999.6M926.4M1.2B1.2B1.3B
Total Stockholder Equity313.5M539.9M414.7M565.8M675.0M708.7M
Retained Earnings(946.4M)(722.0M)(456.1M)(204.9M)(25.2M)(26.4M)
Other Assets293.6M657.5M425.2M198.5M228.2M131.6M
Common Stock Shares Outstanding113.4M113.6M94.3M95.2M86.9M81.9M
Liabilities And Stockholders Equity724.8M999.6M926.4M1.2B1.2B1.3B
Other Stockholder Equity1.3B1.3B870.2M770.0M699.5M1.0B
Total Liab382.7M391.7M400.5M665.7M568.6M442.4M
Short Long Term Debt Total377.1M410.5M394.7M637.9M449.1M332.2M
Other Current Liab5.4M6.0M5.7M31.7M17.2M12.9M
Total Current Liabilities5.4M6.1M5.8M38.8M38.1M25.0M
Other Liab586K219K106K84.2M75.8M49.3M
Property Plant And Equipment Net33K28K12K3.4M3.0M2.9M
Net Debt99.0M139.0M193.1M346.8M255.6M192.9M
Accounts Payable10K66K27K2.9M6.7M7.1M
Cash278.1M246.5M201.5M291.0M193.5M138.1M
Non Current Assets Total293.6M657.5M612.7M788.0M899.3M944.3M
Non Currrent Assets Other139.4M214K108K101.9M87.1M68.4M
Long Term Debt377.1M385.5M394.7M540.4M446.2M321.7M
Cash And Short Term Investments350.8M246.5M201.5M291.0M193.5M235.5M
Net Receivables79.4M93.9M110.7M64.1M84.1M88.3M
Common Stock Total Equity1.0M1.0M1.0M696K800.4K857.6K
Short Term Investments72.7M438.3M483.8M403.0M463.5M486.6M
Non Current Liabilities Total377.3M385.6M394.7M626.9M530.4M426.9M
Other Current Assets80.4M95.6M1.4M32.5M25.9M22.6M
Property Plant And Equipment Gross33K28K12K3.4M3.0M2.9M
Total Current Assets431.2M342.1M313.7M443.5M344.2M281.5M
Common Stock1.0M1.0M696K692K633K845.9K
Property Plant Equipment33K28K12K3.4M3.1M2.9M
Inventory(79.4M)(93.9M)(110.7M)55.9M40.7M42.8M
Net Tangible Assets313.5M539.9M414.7M286.2M329.1M345.5M
Noncontrolling Interest In Consolidated Entity152K5.5M67.9M111.2M127.9M134.3M
Retained Earnings Total Equity(1.5B)(1.1B)(722.0M)(456.1M)(524.6M)(550.8M)
Long Term Debt Total574.4M382.9M377.1M385.5M443.3M463.7M
Capital Surpluse1.3B1.3B1.3B1.3B1.1B1.1B
Deferred Long Term Liab139.1M125.3M111.4M97.6M112.2M122.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.8
Revenue Per Share
5.6
Quarterly Revenue Growth
0.331
Return On Assets
0.0937
The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.